Shopping Cart 0
Cart Subtotal
USD 0

Leap Therapeutics Inc (LPTX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Leap Therapeutics Inc (Leap Therapeutics), formerly HealthCare Pharmaceuticals Inc, is a clinical-stage biopharmaceutical company that develops novel therapeutics to treat patients with cancer. The company's pipeline products include DKN-01, a humanized monoclonal antibody that targets the Dickkopf-1 (DKK-1) protein, intended for the treatment of gastroesophageal cancer, biliary tract cancer, hepatocellular carcinoma, and non-small cell lung cancer; and TRX518, is a humanized anti-GITR (glucocorticoid-induced tumor necrosis factor receptor) monoclonal antibody that enhances the immune system's anti-tumor response and is in Phase 1 clinical trials intended for the treatment of solid tumors. Leap Therapeutics is headquartered in Cambridge, Massachusetts, the US.

Leap Therapeutics Inc (LPTX)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Leap Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Leap Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 10

Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 12

Venture Financing 12

GITR Raises USD 3.25 Million In Seed Financing 12

Partnerships 13

Leap Therapeutics Enters into Co-Development Agreement with Merck and Pfizer 13

Leap Therapeutics Enters into Immunotherapy Agreement with European Organisation for Research and Treatment of Cancer 14

Leap Therapeutics Enters into Agreement with Merck International 15

Merger 16

GITR Merges with HealthCare Pharmaceuticals to Form Leap Therapeutics 16

Licensing Agreements 17

Leap Therapeutics Enters into Licensing Agreement with Lonza Sales 17

Equity Offering 18

Leap Therapeutics Raises USD16.1 Million in Public Offering of Shares 18

Leap Therapeutics Plans to Raise Funds in Secondary Offering of Shares 20

Leap Therapeutics to Raise USD18 Million in Private Placement of Units 21

Macrocure Completes IPO for USD54 Million 23

Acquisition 25

Leap Therapeutics Acquires Macrocure 25

Leap Therapeutics Inc-Key Competitors 27

Leap Therapeutics Inc-Key Employees 28

Leap Therapeutics Inc-Locations And Subsidiaries 29

Head Office 29

Other Locations & Subsidiaries 29

Recent Developments 30

Financial Announcements 30

Aug 08, 2018: Leap Therapeutics reports second quarter 2018 business update and financial results 30

May 11, 2018: Leap Therapeutics Reports First Quarter 2018 Financial Results 32

Feb 23, 2018: Leap Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results 33

Nov 13, 2017: Leap Therapeutics Reports Third Quarter 2017 Financial Results 35

Aug 11, 2017: Leap Therapeutics Reports Second Quarter 2017 Financial Results 36

May 12, 2017: Leap Therapeutics Reports First Quarter 2017 Financial Results 37

May 12, 2017: Leap Therapeutics Q1 net loss increases 38

Mar 31, 2017: Leap Therapeutics Reports Full Year 2016 Financial Results and Progression-Free Survival Data in Advanced Biliary Tract Cancers 39

Product News 40

04/16/2018: Leap Therapeutics Presents Nonclinical and Clinical Data on DKN-01 at AACR 2018 Annual Meeting 40

03/01/2017: Leap Therapeutics to Present Clinical Data on TRX518 at 2017 AACR Annual Meeting 41

03/01/2017: Leap Therapeutics to Present Data on DKN-01 at 2017 AACR Annual Meeting 42

02/03/2017: Leap Therapeutics Presents Biomarker and Efficacy Data at the Cholangiocarcinoma Foundation 2017 Annual Meeting 43

01/19/2017: Leap Therapeutics Presents Biomarker Data from Clinical Study of DKN-01 in Combination with Paclitaxel in Esophageal Cancer 44

Clinical Trials 45

Mar 14, 2018: Leap Therapeutics Provides DKN-01 Program Update and Announces Scientific Presentations at AACR Annual Meeting 45

Jan 16, 2018: Leap Therapeutics Announces First Patient Dosed with TRX518 Combination Therapy in Advanced Solid Tumors Trial 47

Nov 13, 2017: Leap Therapeutics Announces First Patient Dosed with DKN-01 and KEYTRUDA (pembrolizumab) in Esophagogastric Cancer Trial 48

Nov 13, 2017: Leap Therapeutics Provides Update on its Antineoplastic Drug Candidate TRX-518 49

May 17, 2017: Leap Therapeutics Presents Positive DKN-01 Clinical Data in Biliary Tract Cancers at American Society of Clinical Oncology 2017 Annual Meeting 50

May 12, 2017: Leap Therapeutics Provides Update on DKN-01 51

Apr 20, 2017: Leap Therapeutics to Present DKN-01 Clinical Data at American Society of Clinical Oncology 2017 Annual Meeting 52

Apr 03, 2017: Leap Therapeutics Presents Data on DKN-01 at the 2017 AACR Annual Meeting 53

Apr 03, 2017: Leap Therapeutics Presents Non-clinical and Phase 1 Data for TRX518 at the 2017 AACR Annual Meeting 54

Appendix 55

Methodology 55

About GlobalData 55

Contact Us 55

Disclaimer 55


List Of Figure

List of Figures

Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Leap Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Leap Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Leap Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 9

Leap Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 10

Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

GITR Raises USD 3.25 Million In Seed Financing 12

Leap Therapeutics Enters into Co-Development Agreement with Merck and Pfizer 13

Leap Therapeutics Enters into Immunotherapy Agreement with European Organisation for Research and Treatment of Cancer 14

Leap Therapeutics Enters into Agreement with Merck International 15

GITR Merges with HealthCare Pharmaceuticals to Form Leap Therapeutics 16

Leap Therapeutics Enters into Licensing Agreement with Lonza Sales 17

Leap Therapeutics Raises USD16.1 Million in Public Offering of Shares 18

Leap Therapeutics Plans to Raise Funds in Secondary Offering of Shares 20

Leap Therapeutics to Raise USD18 Million in Private Placement of Units 21

Macrocure Completes IPO for USD54 Million 23

Leap Therapeutics Acquires Macrocure 25

Leap Therapeutics Inc, Key Competitors 27

Leap Therapeutics Inc, Key Employees 28

Leap Therapeutics Inc, Subsidiaries 29

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Leap Therapeutics Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.